These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 33773991

  • 1. Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes.
    Haiduk T, Brockmann M, Tillmann RL, Pieper M, Lüsebrink J, Schildgen V, Schildgen O.
    Exp Mol Pathol; 2021 Jun; 120():104634. PubMed ID: 33773991
    [Abstract] [Full Text] [Related]

  • 2. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
    Franczak C, Dubouis L, Gilson P, Husson M, Rouyer M, Demange J, Leroux A, Merlin JL, Harlé A.
    PLoS One; 2019 Jun; 14(2):e0212801. PubMed ID: 30811471
    [Abstract] [Full Text] [Related]

  • 3. Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.
    Van Haele M, Vander Borght S, Ceulemans A, Wieërs M, Metsu S, Sagaert X, Weynand B.
    J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the Idylla KRAS and NRAS mutation test in colorectal cancer tissue.
    Zekri J, Baghdadi MA, Alardati H, Khallaf H, Kabanja JH.
    Exp Mol Pathol; 2019 Oct; 110():104270. PubMed ID: 31207216
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
    Franczak C, Witz A, Geoffroy K, Demange J, Rouyer M, Husson M, Massard V, Gavoille C, Lambert A, Gilson P, Gambier N, Scala-Bertola J, Merlin JL, Harlé A.
    PLoS One; 2020 Oct; 15(1):e0227294. PubMed ID: 31940389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.
    Nagakubo Y, Hirotsu Y, Amemiya K, Oyama T, Mochizuki H, Omata M.
    BMC Med Genomics; 2019 Nov 11; 12(1):162. PubMed ID: 31711486
    [Abstract] [Full Text] [Related]

  • 15. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K, Tsurutani J, Yamanaka T, Yoneshige A, Ito A, Togashi Y, De Velasco MA, Terashima M, Fujita Y, Tomida S, Tamura T, Nakagawa K, Nishio K.
    PLoS One; 2015 Nov 11; 10(5):e0121891. PubMed ID: 25954997
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.
    Haley L, Tseng LH, Zheng G, Dudley J, Anderson DA, Azad NS, Gocke CD, Eshleman JR, Lin MT.
    Mod Pathol; 2015 Oct 11; 28(10):1390-9. PubMed ID: 26226847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.